AZD8055 is primarily used in research settings to study its effects on cellular processes, particularly in the context of cancer biology. It is a potent and selective inhibitor of mTOR (mechanistic target of rapamycin), which plays a critical role in regulating cell growth, proliferation, and survival. By inhibiting mTOR, AZD8055 helps researchers understand the signaling pathways involved in tumor development and progression. This compound is often used in preclinical studies to evaluate its potential as an anticancer agent, as it has shown promise in suppressing the growth of various cancer cell lines. Additionally, AZD8055 is utilized to explore its effects on autophagy, a cellular recycling process that can influence cancer cell survival and resistance to therapy. Its application extends to studying metabolic disorders and other diseases where mTOR signaling is implicated.